ADIENNE SA is an integrated biopharmaceutical group focused on research, development and manufacturing of medicines for rare and severe hematological and immunological diseases. The company provides GMP development and manufacturing services, including lyophilization of cytotoxic finished products in ready-to-use systems (e.g., Multichamber Flexible Bag, FillChoice), and markets products such as TEPADINA® and PHELINUN®.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
PHELINUN® and TEPADINA® for the treatment of certain haematological and other cancers, as well as conditioning prior to haematopoietic stem cell transplantation.
Biotechnological medicinal product
BEGESAND® for first-line treatment of acute graft-versus-host disease of the skin in patients following allogeneic haematopoietic stem cell transplantation.
CDMO services
Analytical development, cleanability and compatibility studies, preformulation, formulation and process development, technology transfer, clinical services, stability programs and commercial manufacturing.
Innovative ready-to-use systems
Ready-to-use systems for cytotoxic injectables with aseptic reconstitution, dilution and direct administration in flexible multi-compartment containers.
Knowledge
No knowledge articles yet
Once ADIENNE SA has claimed this profile, we'll publish editorial articles and case studies here together.